CONTAIN study on convalescent plasma published in JAMA
COVID-19 convalescent plasma showed a likely benefit for patients early in the pandemic before remdesivir and corticosteroids were in use, according to results of a landmark study published in JAMA Internal Medicine that included physician-scientists at UTHealth Houston. UTHealth Houston…
Pages